Fondaparinux Sodium
Catalog No. A17918
Fondaparinux sodium is a factor Xa inhibitor to form the high affinity binding site for the anti-coagulant factor antithrombin III (ATIII).
Catalog Num | A17918 |
---|---|
M. Wt | 1728.03 |
Formula | C31H43N3Na10O49S8 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 114870-03-0 |
Synonyms | Fondaparinux sodium; Fondaparinux sodium salt; PENTA; Arixtra; Xantidar; SR 90107A; IC-85158; SR-90107A; SR90107A; IC 85158; IC85158; |
SMILES | O[C@H]1[C@@H]([C@H](O[C@@]([H])([C@@H]1NS([O-])(=O)=O)O[C@@H]2[C@H](O[C@]([H])([C@@H]([C@H]2O)O)O[C@H]3[C@@H]([C@H]([C@H](O[C@@H]3COS([O-])(=O)=O)O[C@@]4([C@@H](O[C@H]([C@@H]([C@H]4O)OS([O-)(=O)=O)O[C@]5([C@@H]([C@H]([C@H](O[C@@H]5COS([O-])(=O)=O)OC)NS([O-])(=O)=O)O)[H])C([O-])=O)[H])NS([O-])(=O)=O)OS([O-])(=O)=O)C([O-])=O)COS([O-])(=O)=O)O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+] |
Fondaparinux sodium is a factor Xa inhibitor to form the high affinity binding site for the anti-coagulant factor antithrombin III (ATIII).
In vitro | DMSO | 1 mg/mL (0.57 mM) | |
Water | 89 mg/mL (51.5 mM) | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 5.79 mL | 28.93 mL | 57.87 mL |
0.5 mM | 1.16 mL | 5.79 mL | 11.57 mL |
1 mM | 0.58 mL | 2.89 mL | 5.79 mL |
5 mM | 0.12 mL | 0.58 mL | 1.16 mL |
*The above data is based on the productmolecular weight 1728.03. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.